This page lists the SEC filings reported by Perceptive Advisors.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-04-17 | PERCEPTIVE ADVISORS LLC | RHYTHM PHARMACEUTICALS, INC. | 5,143,575 | 8.3% | EDGAR |
| SC 13D/A | 2024-04-17 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 1,261,710 | 4.4% | EDGAR |
| SC 13G/A | 2024-04-15 | PERCEPTIVE ADVISORS LLC | Acrivon Therapeutics, Inc. | 5,360,858 | 17.4% | EDGAR |
| SC 13G | 2024-04-15 | PERCEPTIVE ADVISORS LLC | Contineum Therapeutics, Inc. | 1,566,669 | 8.5% | EDGAR |
| SC 13D/A | 2024-04-10 | PERCEPTIVE ADVISORS LLC | Landos Biopharma, Inc. | 1,486,991 | 47.7% | EDGAR |
| SC 13D/A | 2024-04-03 | PERCEPTIVE ADVISORS LLC | RHYTHM PHARMACEUTICALS, INC. | 3,268,579 | 5.4% | EDGAR |
| SC 13D | 2024-03-20 | PERCEPTIVE ADVISORS LLC | RHYTHM PHARMACEUTICALS, INC. | 3,268,579 | 5.4% | EDGAR |
| SC 13G | 2024-03-14 | PERCEPTIVE ADVISORS LLC | PRECISION BIOSCIENCES INC | 500,000 | 7.9% | EDGAR |
| SC 13G | 2024-03-11 | PERCEPTIVE ADVISORS LLC | ARTIVION, INC. | 2,383,978 | 5.8% | EDGAR |
| SC 13G/A | 2024-03-06 | PERCEPTIVE ADVISORS LLC | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2024-03-01 | PERCEPTIVE ADVISORS LLC | Crinetics Pharmaceuticals, Inc. | 1,488,703 | 1.9% | EDGAR |
| SC 13G | 2024-03-01 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 19,221,743 | 6.9% | EDGAR |
| SC 13D/A | 2024-02-29 | PERCEPTIVE ADVISORS LLC | LianBio | 57,850,841 | 53.4% | EDGAR |
| SC 13G/A | 2024-02-23 | PERCEPTIVE ADVISORS LLC | enVVeno Medical Corp | 1,394,716 | 9.9% | EDGAR |
| SC 13D/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Lyra Therapeutics, Inc. | 12,757,563 | 24.3% | EDGAR |
| SC 13D/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | MeiraGTx Holdings plc | 11,442,562 | 18.0% | EDGAR |
| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Spyre Therapeutics, Inc. | 2,606,679 | 7.2% | EDGAR |
| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Verona Pharma plc | 3,866,214 | 4.8% | EDGAR |
| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 11,979,415 | 4.7% | EDGAR |
| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Evolus, Inc. | 3,963,424 | 6.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.